We are live on ! Find out more
CA

Continental Advisors Portfolio holdings

AUM $196M
1-Year Est. Return 24.19%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.19%
3 Year Est. Return
+67.62%
5 Year Est. Return
+60.86%
10 Year Est. Return
+208.23%
AUM
$358M
AUM Growth
+$33.7M
Cap. Flow
+$17.4M
Cap. Flow %
4.87%
Top 10 Hldgs %
27.79%
Holding
153
New
34
Increased
35
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.01M
2
CVS icon
CVS Health
CVS
+$2.4M
3
WFC icon
Wells Fargo
WFC
+$2.1M
4
TROW icon
T. Rowe Price
TROW
+$1.8M
5
JPM icon
JPMorgan Chase
JPM
+$1.56M

Sector Composition

Rank Sector Weight
1 Financials 31.06%
2 Healthcare 23.03%
3 Consumer Discretionary 1.81%
4 Consumer Staples 1.57%
5 Industrials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROV icon
26
Provident Financial
PROV
$108M
$4.09M 1.14%
209,338
-129,399
-38% -$2.48M
TROW icon
27
CALL
T. Rowe Price
TROW
$24.6B
$4.06M 1.13%
61,000
+30,000
+97% +$2.09M
HRB icon
28
CALL
H&R Block
HRB
$5.06B
$4.03M 1.13%
174,000
-10,000
-5% -$234K
XRAY icon
29
Dentsply Sirona
XRAY
$2.55B
$3.79M 1.06%
63,800
GNW icon
30
Genworth Financial
GNW
$3.8B
$3.63M 1.01%
731,309
-12,500
-2% -$48K
CVS icon
31
PUT
CVS Health
CVS
$136B
$3.56M 0.99%
40,000
-5,000
-11% -$472K
WFC icon
32
CALL
Wells Fargo
WFC
$261B
$3.54M 0.99%
+80,000
New +$3.83M
ENVA icon
33
Enova International
ENVA
$5.42B
$3.41M 0.95%
351,923
-86,547
-20% -$773K
RATE
34
DELISTED
Bankrate Inc
RATE
$3.4M 0.95%
401,274
+39,400
+11% +$313K
CAH icon
35
Cardinal Health
CAH
$52.9B
$3.38M 0.94%
43,500
BSX icon
36
Boston Scientific
BSX
$64.8B
$3.32M 0.93%
139,600
WDR
37
CALL
DELISTED
Waddell & Reed Financial, Inc.
WDR
$3.16M 0.88%
174,000
+130,000
+295% +$2.37M
AVP
38
DELISTED
Avon Products, Inc.
AVP
$3.11M 0.87%
549,155
-70,100
-11% -$350K
XLF icon
39
CALL
State Street Financial Select Sector SPDR ETF
XLF
$55.1B
$3.09M 0.86%
160,000
-130,482
-45% -$2.69M
CERN
40
DELISTED
Cerner Corp
CERN
$3.09M 0.86%
50,000
PDCO
41
DELISTED
Patterson Companies, Inc.
PDCO
$3.07M 0.86%
66,764
TAX
42
DELISTED
Liberty Tax, Inc. Class A
TAX
$3.05M 0.85%
238,936
+30,206
+14% +$409K
GILD icon
43
Gilead Sciences
GILD
$162B
$2.93M 0.82%
+37,000
New +$3.01M
WT icon
44
WisdomTree
WT
$3.01B
$2.86M 0.8%
277,600
+55,500
+25% +$578K
NUAN
45
DELISTED
Nuance Communications, Inc.
NUAN
$2.8M 0.78%
222,955
+5,775
+3% +$75.7K
THC icon
46
Tenet Healthcare
THC
$17.1B
$2.74M 0.77%
121,070
+16,000
+15% +$416K
NXTM
47
DELISTED
NxStage Medical Inc.
NXTM
$2.74M 0.76%
109,564
-10,000
-8% -$233K
LH icon
48
Labcorp
LH
$23.9B
$2.72M 0.76%
23,047
JPM.WS
49
DELISTED
JPMorgan Chase
JPM.WS
$2.7M 0.75%
109,683
FBNC icon
50
First Bancorp
FBNC
$2.62B
$2.65M 0.74%
133,904

Similar funds

Continental Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Continental Advisors held 153 positions worth $358M, up 10% from $324M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Continental Advisors deployed $17.4M of net new capital in Q3 2016, opening 34 new positions and adding to 35 existing holdings. Its largest new stake was Gilead Sciences: 37,000 shares worth $2.93M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Cherry Hill Mortgage Investment Corp, an estimated $2.8M trimmed.

  • Continental Advisors's largest Q3 2016 buy was Gilead Sciences: 37,000 shares worth $2.93M.
  • Continental Advisors added most to CVS Health in Q3 2016, an estimated $2.4M increase.
  • Continental Advisors's biggest Q3 2016 reduction was Cherry Hill Mortgage Investment Corp, cutting an estimated $2.8M.
  • Continental Advisors fully exited Sanofi in Q3 2016, selling an estimated $1.85M.
  • Continental Advisors's ten largest holdings make up 28% of its $358M portfolio in Q3 2016.
  • Continental Advisors opened 34 new positions and closed 16 in Q3 2016.
  • Continental Advisors's portfolio value rose 10% quarter-over-quarter to $358M.

Based on Continental Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.